VG Life Sciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$2,530,247 over the previous period. Total operating expenses were $20,343.
Profit Margin
| 2013 | 0 | -8.49M | |
|---|---|---|---|
| 2014 | 0 | -8.94M | |
| 2017 | 0 | -268.43K | |
| 2019 | 0 | -268.43K | |
| 2020 | 0 | -1.45M | |
| 2021 | 0 | -1.24M | |
| 2022 | 0 | 2.11M | |
| 2023 | 0 | -2.53M |
VGLS Income Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 865.70K | 808.51K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 20.34K | 23.76K | 1.16M | 1.18M | 34.40K | 34.40K | 4.14M | 3.90M |
Operating income | -20.34K | -23.76K | -1.16M | -1.18M | 34.40K | 34.40K | -4.14M | -3.90M |
Other income (expenses), net | -2.50M | 2.13M | -75.70K | -268.43K | -302.84K | -337.24K | -2.08M | -3.57M |
Income before tax | -2.53M | 2.11M | -1.24M | -1.45M | -302.84K | -302.84K | -6.22M | -7.47M |
Income tax expense | -167.89K | 0 | 0 | -206.29K | -34.40K | -34.40K | 2.72M | 1.01M |
Net income | -2.53M | 2.11M | -1.24M | -1.45M | -268.43K | -268.43K | -8.94M | -8.49M |
Earnings per share | ||||||||
Basic EPS | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.32 | -1.04 |
Diluted EPS | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.32 | -1.04 |